









Markets
/
Stocks
/
nasdaq-bcpc
/

Balchem Corp

BCPC

173.160USD

-0.560-0.32%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

5.61BMarket Cap

37.56P/E TTM



Balchem Corp

173.160

-0.560-0.32%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Balchem Corp

Currency: USD Updated: 2026-02-06

Key Insights

Balchem Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 69 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 191.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Balchem Corp's Score

Industry at a Glance

Industry Ranking

11 / 69

Overall Ranking

76 / 4521

Industry

Chemicals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Balchem Corp Highlights

StrengthsRisks

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 953.68M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.

Fairly Valued

The company’s latest PB is 4.32, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 30.08M shares, increasing 0.06% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 191.00 shares of this stock.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

191.000

Target Price

+9.95%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Balchem Corp is 9.46, ranking 4 out of 69 in the Chemicals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 267.56M, representing a year-over-year increase of 11.51%, while its net profit experienced a year-over-year increase of 19.07%.

Score

Industry at a Glance

Previous score

9.46

Change



Financials

9.17

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.77

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.71

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.64

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Balchem Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Balchem Corp is 3.54, ranking 69 out of 69 in the Chemicals industry. Its current P/E ratio is 37.56, which is 33.31% below the recent high of 50.07 and 18.98% above the recent low of 30.43.

Score

Industry at a Glance

Previous score

3.54

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 11/69

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Balchem Corp is 7.33, ranking 31 out of 69 in the Chemicals industry. The average price target is 191.00, with a high of 220.00 and a low of 162.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

191.000

Target Price

+9.95%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Balchem Corp

BCPC

Apple Inc

AAPL

Ge Vernova Inc

GEV

Tapestry Inc

TPR

FMC Corp

FMC

Avantor Inc

AVTR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Balchem Corp is 9.21, ranking 19 out of 69 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 180.52 and the support level at 161.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.41

Change

-0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.760

Buy

RSI(14)

67.009

Neutral

STOCH(KDJ)(9,3,3)

74.410

Neutral

ATR(14)

3.646

Low Volatility

CCI(14)

132.089

Buy

Williams %R

26.077

Buy

TRIX(12,20)

0.375

Sell

StochRSI(14)

42.401

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

172.608

Buy

MA10

170.486

Buy

MA20

167.316

Buy

MA50

160.137

Buy

MA100

155.741

Buy

MA200

158.184

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Balchem Corp is 10.00, ranking 1 out of 69 in the Chemicals industry. The latest institutional shareholding proportion is 92.73%, representing a quarter-over-quarter increase of 0.07%. The largest institutional shareholder is The Vanguard, holding a total of 3.87M shares, representing 11.95% of shares outstanding, with 1.39% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

4.35M

-2.00%

The Vanguard Group, Inc.

Star Investors

3.89M

-0.11%

Conestoga Capital Advisors, LLC

1.27M

+10.93%

State Street Investment Management (US)

1.20M

-2.04%

Wasatch Global Investors Inc

Star Investors

1.08M

+12.62%

Geode Capital Management, L.L.C.

995.83K

+1.51%

Geneva Capital Management LLC

987.98K

+10.32%

Dimensional Fund Advisors, L.P.

579.05K

+0.64%

Norges Bank Investment Management (NBIM)

469.08K

+8.97%

JP Morgan Asset Management

459.75K

+18.17%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Balchem Corp is 9.54, ranking 4 out of 69 in the Chemicals industry. The company's beta value is 0.95. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Balchem Corp’s latest ESG disclosure leads the Chemicals industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.